Literature DB >> 1828056

Effect of cyclosporin on immune complex deposition in murine glomerulonephritis.

D G Quinn1, J S Fennell, O Sheils, E F Gaffney, C F Feighery.   

Abstract

Chronic glomerulonephritis (GN) was induced in N/M mice by daily injections of human serum albumin (HSA). The glomerular lesion was similar to that observed in human membranous GN and was characterized by intense mesangial and capillary loop immunofluorescent staining for HSA, IgG and C3. Electron microscopic examination revealed numerous electron-dense deposits in the mesangium and along the subepithelial side of the glomerular basement membrane, the latter deposits being associated with membranous spikes. Chronically injected mice that had been treated with cyclosporin (CsA) from Day 1 had different patterns of immune complex deposition. Mesangial deposition was apparently unaltered but no subepithelial deposits or spikes were evident. In addition, only two out of 21 HSA-injected mice which began CsA treatment on Day 21 had subepithelial deposits. There was no significant difference in serum levels of HSA-specific IgG between the three groups of mice. CsA treatment would therefore appear to ameliorate the immunopathology of antigen-induced glomerulonephritis in this model without affecting serum antibody levels, and may be of therapeutic value in the treatment of human membranous GN.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1828056      PMCID: PMC1384376     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Role of antigenic charge and antibody avidity on the glomerular immune complex localization in serum sickness of mice.

Authors:  A Koyama; H Inage; M Kobayashi; Y Ohta; M Narita; S Tojo; J S Cameron
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

3.  Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.

Authors:  H C Gunn; B Ryffel
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

Review 4.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

5.  Influence of antibody avidity on glomerular immune complex localization.

Authors:  S S Iskandar; J C Jennette
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

6.  Rat bovine serum albumin (BSA) nephritis. VI. The influence of chemically altered antigen.

Authors:  T Yamamoto; S Miyazaki; K Kawasaki; E Yaoita; I Kihara
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

7.  Immune complexes with cationic antibodies deposit in glomeruli more effectively than cationic antibodies alone.

Authors:  M Mannik; V J Gauthier; S A Stapleton; L Y Agodoa
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

8.  Relationship of the quality and quantity of circulating anti-BSA antibodies to the severity of glomerulonephritis in rats with chronic serum sickness.

Authors:  B Noble; M W Steward; A Vladutiu; J R Brentjens
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

9.  Cyclosporin A prevents proteinuria in an active model of membranous nephropathy in rats.

Authors:  F Thaiss; W Schoeppe; J G Willaredt-Stoll; S Batsford; M J Mihatsch
Journal:  Lab Invest       Date:  1989-12       Impact factor: 5.662

10.  Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis.

Authors:  S K Datta; H Patel; D Berry
Journal:  J Exp Med       Date:  1987-05-01       Impact factor: 14.307

View more
  3 in total

1.  Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.

Authors:  B Ryffel; B D Car; H Gunn; D Roman; P Hiestand; M J Mihatsch
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

2.  Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.

Authors:  Ruyi Liao; Qinghua Liu; Zhihua Zheng; Jinjin Fan; Wenxing Peng; Qingyu Kong; Huijuan He; Shicong Yang; Wenfang Chen; Xueqing Tang; Xueqing Yu
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

3.  Comparative evaluation of nephroprotective potential of resveratrol and piperine on nephrotic BALB/c mice.

Authors:  Rahul Motiram Kakalij; B Dinesh Kumar; Prakash Vamanrao Diwan
Journal:  Indian J Pharmacol       Date:  2016 Jul-Aug       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.